In addition, LRRK2 G2019S carriers without clinical diagnosed PD may also be ideal as prodromal PD candidates for clinical trials
Combining incretin-based drugs and RAAS inhibitors: more cons than pros
See our Privacy Policy for full details, or read more about our approach to data, science, and privacy on our Science page
However, when taking GLP-1 medications like Semaglutide, its crucial to approach exercise differently
Tirzepatide and semaglutide are generally safe, but they may not be suitable for everyone, including: People with a personal or family history of thyroid cancer or multiple endocrine neoplasia syndrome type 2 (MEN2) People with a personal or family history of pancreatitis People with known hypersensitivity to any component of the medication People who are pregnant, breastfeeding, and planning to become pregnant Always consult a healthcare provider before starting a new medication
GLP-1RAs were documented to normalise insulin resistance and modulate dopaminergic signalling reducing anhedonia and influencing food cue reactivity
